RxDoctor Payments Data

Phillip Ge, MD

Gastroenterology · Houston, TXNPI 1194014266

Payments from drug & device makers

$117,308in general payments, 2019–2025

Across 200 payments — averaging $586.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$62K
  • Fujifilm Healthcare Americas Corporation$15K
  • Olympus Corporation Of The Americas$15K
  • Ovesco Endoscopy USA, Inc.$12K
  • Neptune Medical Inc.$8K
  • Pentax Of America, Inc.$2K
  • plus $3K from 9 others

What the payments were for

  • Consulting fees$37,61232%
  • Speaking & faculty fees$64,53855%
  • Grants$290%
  • Travel & lodging$10,0639%
  • Food & beverage$5,0674%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific115$62,137
Fujifilm Healthcare Americas Corporation15$15,448
Olympus Corporation Of The Americas25$14,711
Ovesco Endoscopy USA, Inc.4$12,163
Neptune Medical Inc.2$7,924
Pentax Of America, Inc.7$2,267
Olympus Corporation3$1,426
Olympus America Inc.9$316
Cook Medical LLC4$315
Conmed Corporation7$217
ERBE USA Inc1$150
Medtronic4$118
Apollo Endosurgery US Inc2$67
Ambu Inc.1$27
Creo Medical Inc.1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$117,308 in reported general payments places this provider in the 90th percentile of 1,350 gastroenterology providers in Texas.

See all gastroenterology providers in Texas

Medicare billing

Part B allowed, 2024
$112,536
Medicare patients
332
Services billed
739

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole36$576

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →